Research location
Greenbelt
Maryland, United States
Advertisement
Research activity in Greenbelt
Maryland, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 38 trials and 39 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Greenbelt
38 linked trials · page 1 of 1Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)NCT04455646 · 2019-08-26 · 1 site observation
UNKNOWN
Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood TestNCT03810144 · 2018-10-22 · 1 site observation
COMPLETED
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)NCT02380274 · 2015-03-27 · 1 site observation
COMPLETED
Pyridorin in Diabetic NephropathyNCT02156843 · 2014-06-01 · 1 site observation
TERMINATED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerNCT01981109 · 2012-01-01 · 1 site observation
TERMINATED
Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate CancerNCT01487863 · 2011-12-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerNCT01322490 · 2011-11-28 · 1 site observation
COMPLETED
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerNCT01415960 · 2011-09-01 · 1 site observation
COMPLETED
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerNCT01306890 · 2011-01-27 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesNCT01068665 · 2010-03-01 · 1 site observation
COMPLETED
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossNCT00925600 · 2009-11-30 · 1 site observation
COMPLETED
Open Label Study of Sipuleucel-T in Metastatic Prostate CancerNCT00901342 · 2009-10-01 · 2 site observations
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
A Study of Degarelix in Patients With Prostate CancerNCT00928434 · 2009-05-01 · 1 site observation
COMPLETED
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate CancerNCT00838201 · 2009-02-01 · 1 site observation
COMPLETED
A Study of Leuprolide to Treat Prostate CancerNCT00626431 · 2008-02-01 · 1 site observation
COMPLETED
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenNCT00612742 · 2008-01-01 · 1 site observation
COMPLETED
Expanded Access Program for Maraviroc At Multiple CentersNCT00426660 · 2007-02-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenNCT00363311 · 2006-07-01 · 1 site observation
COMPLETED
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisNCT00109408 · 2005-07-01 · 1 site observation
COMPLETED
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsNCT00196339 · 2005-06-01 · 1 site observation
COMPLETED
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)NCT00106691 · 2005-01-01 · 1 site observation
COMPLETED
Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)NCT00849290 · 2004-04-01 · 1 site observation
COMPLETED
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal TherapyNCT00216060 · 2003-10-01 · 1 site observation
TERMINATED
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyNCT00065442 · 2003-07-01 · 1 site observation
COMPLETED
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 1 site observation
COMPLETED
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate CancerNCT00056654 · 2003-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis PatientsNCT00650455 · 2003-02-01 · 1 site observation
COMPLETED
Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsNCT00117312 · 2002-10-01 · 1 site observation
TERMINATED
Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486NCT00117949 · 2002-04-01 · 1 site observation
COMPLETED
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisNCT00035997 · 2002-04-01 · 1 site observation
COMPLETED
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of RecurrenceNCT00045123 · 2002-02-01 · 1 site observation
UNKNOWN
A Long-term Safety Study of Infliximab (Remicade)NCT00261976 · 2002-02-01 · 1 site observation
COMPLETED
ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid ArthritisNCT00048321 · 2002-01-01 · 1 site observation
COMPLETED
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerNCT00036556 · 2001-06-01 · 1 site observation
COMPLETED
Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerNCT00657904 · 1995-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.